Mereo Biopharma Group PLC banner

Mereo Biopharma Group PLC
NASDAQ:MREO

Watchlist Manager
Mereo Biopharma Group PLC Logo
Mereo Biopharma Group PLC
NASDAQ:MREO
Watchlist
Price: 0.329 USD 2.81% Market Closed
Market Cap: $52.4m

Profitability Summary

Mereo Biopharma Group PLC's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Mereo Biopharma Group PLC

Margins Comparison
Mereo Biopharma Group PLC Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
UK
Mereo Biopharma Group PLC
NASDAQ:MREO
52.4m USD
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
371.7B USD
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
189.2B USD
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
174.3B USD
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
112.8B USD
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.9B USD
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
43.6B EUR
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
66.6B AUD
Loading...
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Mereo Biopharma Group PLC Competitors

Country Company Market Cap ROE ROA ROCE ROIC
UK
Mereo Biopharma Group PLC
NASDAQ:MREO
52.4m USD
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
371.7B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
189.2B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
174.3B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
112.8B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.9B USD
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
43.6B EUR
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
66.6B AUD
Loading...
Loading...
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Mereo Biopharma Group PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett